- Safety and Immunogenicity of a New Trivalent Inactivated Split-virus Influenza Vaccine in Healthy Korean Children: A Randomized, Double-blinded, Active-controlled, Phase III Study
-
Kang JH, Oh CE, Lee J, Lee SY, Cha SH, Kim DS, Kim HH, Lee JH, Kim JT, Ma SH, Hong YJ, Cheong HJ, Lee HJ
- KMID: 1123441
- J Korean Med Sci.
- 2011 Nov;26(11):1421-1427.
- doi: 10.3346/jkms.2011.26.11.1421
We report results of a randomized, double-blinded, active-controlled, phase III study conducted to evaluate the immunogenicity and safety of a new trivalent inactivated split-virus influenza vaccine (GC501) manufactured by the... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunogenicity and Safety of Trivalent Split Influenza Vaccine in Healthy Korean Adults with Low Pre-Existing Antibody Levels: An Open Phase I Trial
-
Kang K, Han S, Hong T, Jeon S, Paek J, Kang JH, Yim DS
- KMID: 2427152
- Yonsei Med J.
- 2016 Nov;57(6):1354-1360.
- doi: 10.3349/ymj.2016.57.6.1354
PURPOSE: A phase I clinical trial was conducted to evaluate the immunogenicity and safety of newly developed egg-cultivated trivalent inactivated split influenza vaccine (TIV) in Korea. MATERIALS AND METHODS: The TIV... -
- CITED
-
- Close
- SHARE
-
- Close
